NASDAQ:ICCC - ImmuCell Stock Price, News, & Analysis

$6.78
+0.28 (+4.31 %)
(As of 06/27/2019 04:54 AM ET)
Today's Range
$6.50
Now: $6.78
$6.78
50-Day Range
$6.00
MA: $6.42
$6.8952
52-Week Range
$5.55
Now: $6.78
$9.30
Volume10,700 shs
Average Volume8,812 shs
Market Capitalization$48.88 million
P/E RatioN/A
Dividend YieldN/A
Beta1.16
ImmuCell Corporation, an animal health company, develops, acquires, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company offers First Defense, an orally delivered scours preventive product for calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic. In addition, the company is involved in developing Re-Tain, a Nisin-based treatment of subclinical mastitis in lactating dairy cows; and offers Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. ImmuCell Corporation sells its products through animal health distributors. The company was founded in 1982 and is headquartered in Portland, Maine.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ICCC
CUSIPN/A
Phone207-878-2770

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$10.99 million
Book Value$3.96 per share

Profitability

Net Income$-2,320,000.00

Miscellaneous

Employees47
Market Cap$48.88 million
Next Earnings Date8/12/2019 (Estimated)
OptionableNot Optionable

Receive ICCC News and Ratings via Email

Sign-up to receive the latest news and ratings for ICCC and its competitors with MarketBeat's FREE daily newsletter.

ImmuCell (NASDAQ:ICCC) Frequently Asked Questions

What is ImmuCell's stock symbol?

ImmuCell trades on the NASDAQ under the ticker symbol "ICCC."

How were ImmuCell's earnings last quarter?

ImmuCell Co. (NASDAQ:ICCC) posted its quarterly earnings results on Monday, May, 13th. The biotechnology company reported $0.03 earnings per share for the quarter. The biotechnology company earned $4.41 million during the quarter. ImmuCell had a negative net margin of 15.62% and a negative return on equity of 5.71%. View ImmuCell's Earnings History.

When is ImmuCell's next earnings date?

ImmuCell is scheduled to release their next quarterly earnings announcement on Monday, August 12th 2019. View Earnings Estimates for ImmuCell.

Has ImmuCell been receiving favorable news coverage?

News stories about ICCC stock have been trending neutral this week, InfoTrie reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ImmuCell earned a media sentiment score of 0.5 on InfoTrie's scale. They also assigned media coverage about the biotechnology company a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for ImmuCell.

Are investors shorting ImmuCell?

ImmuCell saw a increase in short interest during the month of June. As of June 15th, there was short interest totalling 7,500 shares, an increase of 33.9% from the May 15th total of 5,600 shares. Based on an average trading volume of 11,500 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.2% of the shares of the stock are short sold. View ImmuCell's Current Options Chain.

Who are some of ImmuCell's key competitors?

What other stocks do shareholders of ImmuCell own?

Who are ImmuCell's key executives?

ImmuCell's management team includes the folowing people:
  • Mr. Michael F. Brigham, Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director (Age 58)
  • Dr. Joseph H. Crabb, VP & Chief Scientific Officer (Age 64)
  • Ms. Bobbi Jo Brockmann, VP of Sales & Marketing and Director (Age 42)
  • Ms. Elizabeth L. Williams, VP of Manufacturing Operations (Age 63)

How do I buy shares of ImmuCell?

Shares of ICCC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ImmuCell's stock price today?

One share of ICCC stock can currently be purchased for approximately $6.78.

How big of a company is ImmuCell?

ImmuCell has a market capitalization of $48.88 million and generates $10.99 million in revenue each year. ImmuCell employs 47 workers across the globe.View Additional Information About ImmuCell.

What is ImmuCell's official website?

The official website for ImmuCell is http://www.immucell.com/.

How can I contact ImmuCell?

ImmuCell's mailing address is 56 EVERGREEN DR, PORTLAND ME, 04103. The biotechnology company can be reached via phone at 207-878-2770 or via email at [email protected]


MarketBeat Community Rating for ImmuCell (NASDAQ ICCC)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  103 (Vote Outperform)
Underperform Votes:  71 (Vote Underperform)
Total Votes:  174
MarketBeat's community ratings are surveys of what our community members think about ImmuCell and other stocks. Vote "Outperform" if you believe ICCC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICCC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/27/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel